Pharmacokinetics of Multiple Oral Doses of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet, Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet and Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet at Steady State in Healthy Male Subjects: an Open-label, Randomised, Multiple-dose, Three Treatment, Three-period, Six-sequence Crossover Study
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Amlodipine/telmisartan; Telmisartan/hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 06 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Nov 2014 Planned End Date changed from 1 Oct 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
- 05 Nov 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.